Moore RD - Search Results

1

Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research Network.

Griffith DC, Farmer C, Gebo KA, Berry SA, Aberg J, Moore RD, Gaur AH, Mathews WC, Beil R, Korthuis PT, Nijhawan AE, Rutstein RM, Agwu AL; HIV Research Network. Griffith DC, et al. Among authors: moore rd. HIV Med. 2019 Feb;20(2):169-174. doi: 10.1111/hiv.12695. Epub 2018 Dec 18. HIV Med. 2019. PMID: 30561888 Free PMC article.

2

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.

Gebo KA, Moore RD, Keruly JC, Chaisson RE. Gebo KA, et al. Among authors: moore rd. J Infect Dis. 1996 Apr;173(4):857-62. doi: 10.1093/infdis/173.4.857. J Infect Dis. 1996. PMID: 8603963

3

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD. Eldred LJ, et al. Among authors: moore rd. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25. doi: 10.1097/00042560-199806010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9637576

4

Costs of HIV medical care in the era of highly active antiretroviral therapy.

Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Gebo KA, et al. Among authors: moore rd. AIDS. 1999 May 28;13(8):963-9. doi: 10.1097/00002030-199905280-00013. AIDS. 1999. PMID: 10371178

5

Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens.

Hall CS, Raines CP, Barnett SH, Moore RD, Gallant JE. Hall CS, et al. Among authors: moore rd. AIDS. 1999 Jul 9;13(10):1207-12. doi: 10.1097/00002030-199907090-00009. AIDS. 1999. PMID: 10416524

6

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Lucas GM, Chaisson RE, Moore RD. Lucas GM, et al. Among authors: moore rd. Ann Intern Med. 1999 Jul 20;131(2):81-7. doi: 10.7326/0003-4819-131-2-199907200-00002. Ann Intern Med. 1999. PMID: 10419445

7

Natural history of HIV infection in the era of combination antiretroviral therapy.

Moore RD, Chaisson RE. Moore RD, et al. AIDS. 1999 Oct 1;13(14):1933-42. doi: 10.1097/00002030-199910010-00017. AIDS. 1999. PMID: 10513653

8

Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.

Gebo KA, Diener-West M, Moore RD. Gebo KA, et al. Among authors: moore rd. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):143-52. doi: 10.1097/00126334-200106010-00009. J Acquir Immune Defic Syndr. 2001. PMID: 11404536

9

Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz.

Lucas GM, Chaisson RE, Moore RD. Lucas GM, et al. Among authors: moore rd. AIDS. 2001 Sep 7;15(13):1679-86. doi: 10.1097/00002030-200109070-00011. AIDS. 2001. PMID: 11546943

10

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.

Sterling TR, Chaisson RE, Moore RD. Sterling TR, et al. Among authors: moore rd. AIDS. 2001 Nov 23;15(17):2251-7. doi: 10.1097/00002030-200111230-00006. AIDS. 2001. PMID: 11698698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

905 results

Search Page